Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Laboratory evaluation of 185 commercial assays for detecting SARS-CoV-2: the UK response for mass testing

Bown A., Peto T., Sweed A., Catton M., Nelthorpe-Cowne J., Benford T., Wallis R., Conti-Frith H., Alexandridou A., Gill R., Milroy C., McKee DF., Perumal PK., Truelove E., Tiley S., McLeod NP., Rowe C., Hammond P., Hallis B., Kulasegaran-Shylini R., Blandford E., Gronert A., Vaughan A., Elderfield R., Wright D., Chadwick J., Choi B-S., Bailey D., D'Arcangelo S., Otter A., Owen J., Baker NE., Richardson A., Withycombe K., Nevols J., Rayment B., Setterfield L., Cooper C., Curran-French M., Bewley KR., Coombes NS., Richards KS., Burton C., Burton JE., Hicks B., Bradley H., Gernon J., Harker G., Lahert P., Carr O., Kelly C., Ellis A., Afrough B., Chamberlain J., Findlay-Wilson S., Flett L., Collinge T., Robinson D., Oliver L., Hopkins S., Crook D., Agrawal S., Fordham H., Fowler T., Sienkiewicz A., Walker AS., Bell SJ., Vipond R.